Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection

International Journal of Antimicrobial Agents

Volumn 34, Issue 5, 2009, Pages 471-473

  Atkins, Helen S ^a   Spencer, Stephen ^b   Brew, Simon D ^b   Laws, Thomas R ^a   Thirlwall, Rachel E ^b   MacMillan, Alastair P ^b   Brooks, Timothy J G ^a   Simpson, Andrew J H ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Antibiotic; Brucella; Fluoroquinolone; Gatifloxacin; Mouse; Moxifloxacin

Indexed keywords

DOXYCYCLINE; GATIFLOXACIN; MOXIFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BRUCELLOSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; AZA COMPOUNDS; BRUCELLA MELITENSIS; BRUCELLOSIS; COLONY COUNT, MICROBIAL; DOXYCYCLINE; FEMALE; FLUOROQUINOLONES; MICE; MICE, INBRED BALB C; QUINOLINES; SPLEEN; TREATMENT OUTCOME;

EID: 69949172421     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.06.018     Document Type: Article

References (6)

1. Roushan M.R.H., Mohraz M., Hajlahmadi M., Ramzani A., and Valayati A.A. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis 42 (2006) 1075-1080
2. Kilic S., Dizbay M., and Cabadak H. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis. J Chemother 20 (2008) 33-37
3. Trujillano-Martin I., Garcia-Sanchez E., Martinez I.M., Fresnadillo M.J., Garcia-Sanchez J.E., and Garcia-Rodriguez J.A. In vitro activities of six new fluoroquinolones against Brucella melitensis. Antimicrob Agents Chemother 43 (1999) 194-195
4. Yamazhan T., Aydemir S., Tunger A., Serter D., and Gokengin D. In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey. Med Princ Pract 14 (2005) 413-416
5. Kocagöz S., Akova M., Altun B., Güur D., and Hasçelik G. In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey. Clin Microbiol Infect 8 (2002) 240-242
6. Sezak N., Kuruuzum Z., Cakir N., and Yuce A. Comparison of rifampicin and moxifloxacin efficacy in an experimental model of animal brucellosis. J Chemother 20 (2008) 58-62